admin

Sanobiotec Unveils Ambition To Become Leading Global ‘Minor Cannabinoid’ Company

Sanobiotec Earns Certifications for Quality Management and Cosmetics Production and Control (ISO 9001:2015, ISO 22716:2007)

The Power of Synthetic Cannabinoids and Why Big Pharma Prefers Them

Extracting cannabinoids at scale: how chromatography is paving the way for pure compounds

Sanobiotec Refines Production of CBC: Non-psychoactive Cannabinoid with Unique Therapeutic Potential

EIHA Consortium Submits Novel Foods Application to FSA

Natural vs Synthetic: Do ‘green’ cannabinoids always come out on top?

The Budding Field of Cannabis Pharmaceuticals

Minor cannabinoid could “revolutionise” autism medication

Firm creates rare cannabinoid used in chronic disease treatment

Exploring nuances of cannabinoid bioavailability: how water-soluble products can lead to greater absorption

Biotechnology | Go Vilnius

Sanobiotec taps into potential of minor cannabinoids

Deepening the search for cannabis plant’s best kept secrets

When collaboration is more vital than ever, you can still rely on BIO to bring the industry together.